SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-007093
Filing Date
2008-11-10
Accepted
2008-11-10 15:46:48
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 PENWEST PHARMACEUTICALS CO. b72627pce10vq.htm 10-Q 370801
2 EX-10.1 SECOND AMENDMENT, DATED JULY 14, 2008, TO THE AMENDED AND RESTATED STRAT b72627pcexv10w1.htm EX-10.1 11721
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b72627pcexv31w1.htm EX-31.1 8115
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b72627pcexv31w2.htm EX-31.2 8434
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b72627pcexv32w1.htm EX-32.1 2897
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b72627pcexv32w2.htm EX-32.2 3013
  Complete submission text file 0000950135-08-007093.txt   406425
Mailing Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120
Business Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120 877-736-9378
PENWEST PHARMACEUTICALS CO (Filer) CIK: 0001047188 (see all company filings)

IRS No.: 911513032 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23467 | Film No.: 081175471
SIC: 2834 Pharmaceutical Preparations